Pfizer Inc. (LON:0Q1N)

Pfizer Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	1,043	2,853	416	1,944	1,786
Short-Term Investments	-	19,434	9,837	22,316	29,125	10,437
Trading Asset Securities	-	-	-	-	4	18
Cash & Short-Term Investments	20,477	20,477	12,690	22,732	31,073	12,241
Cash Growth	71.66%	61.36%	-44.18%	-26.84%	153.84%	26.21%
Accounts Receivable	-	11,463	11,566	10,952	11,479	7,913
Other Receivables	-	3,314	3,978	3,577	4,266	3,264
Receivables	-	14,777	15,544	14,529	15,745	11,177
Inventory	-	10,851	10,189	8,981	9,059	8,020
Other Current Assets	-	4,253	4,910	5,017	3,816	3,629
Total Current Assets	-	50,358	43,333	51,259	59,693	35,067
Property, Plant & Equipment	-	20,682	21,864	19,276	17,721	15,131
Long-Term Investments	-	2,107	15,382	14,926	21,348	20,379
Goodwill	-	68,527	67,783	51,375	49,208	49,556
Other Intangible Assets	-	55,411	64,900	43,370	25,146	28,337
Long-Term Deferred Tax Assets	-	6,600	1,800	4,800	1,600	900
Other Long-Term Assets	-	9,711	11,439	12,199	6,760	4,859
Total Assets	-	213,396	226,501	197,205	181,476	154,229
Accounts Payable	-	5,633	6,710	6,809	5,578	4,283
Accrued Expenses	-	12,005	9,224	8,316	7,671	6,498
Short-Term Debt	-	3,199	8,096	385	605	701
Current Portion of Long-Term Debt	-	3,775	2,270	2,570	1,636	2,002
Current Portion of Leases	-	356	527	620	449	320
Current Income Taxes Payable	-	2,910	2,349	1,587	1,266	1,049
Current Unearned Revenue	-	1,511	2,700	2,520	3,067	2,070
Other Current Liabilities	-	13,606	15,918	19,331	22,399	8,997
Total Current Liabilities	-	42,995	47,794	42,138	42,671	25,920
Long-Term Debt	-	57,802	61,813	33,205	36,195	37,133
Long-Term Leases	-	2,286	2,626	2,597	2,510	1,108
Long-Term Deferred Tax Liabilities	-	2,122	640	1,023	349	4,063
Other Long-Term Liabilities	-	17,579	22,173	20,075	18,564	17,121
Total Liabilities	-	124,899	137,213	101,288	104,013	90,756
Common Stock	-	480	478	476	473	470
Additional Paid-In Capital	-	93,603	92,631	91,802	90,591	88,674
Retained Earnings	-	116,725	118,353	125,656	103,394	90,392
Treasury Stock	-	-114,763	-114,487	-113,969	-111,361	-110,988
Comprehensive Income & Other	-	-7,842	-7,961	-8,304	-5,896	-5,310
Total Common Equity	88,203	88,203	89,014	95,661	77,201	63,238
Minority Interest	-	294	274	256	262	235
Shareholders' Equity	88,497	88,497	89,288	95,917	77,463	63,473
Total Liabilities & Equity	-	213,396	226,501	197,205	181,476	154,229
Total Debt	67,418	67,418	75,332	39,377	41,395	41,264
Net Cash (Debt)	-46,941	-46,941	-62,642	-16,645	-10,322	-29,023
Net Cash Per Share	-8.23	-8.24	-10.97	-2.90	-1.81	-5.15
Filing Date Shares Outstanding	5,675	5,667	5,647	5,619	5,623	5,578
Total Common Shares Outstanding	5,675	5,667	5,646	5,616	5,620	5,567
Working Capital	-	7,363	-4,461	9,121	17,022	9,147
Book Value Per Share	15.56	15.56	15.77	17.03	13.74	11.36
Tangible Book Value	-35,735	-35,735	-43,669	916	2,847	-14,655
Tangible Book Value Per Share	-6.31	-6.31	-7.73	0.16	0.51	-2.63
Land	-	291	353	368	423	443
Buildings	-	9,036	9,046	8,832	9,001	8,998
Machinery	-	20,612	19,661	17,373	16,710	15,484
Construction In Progress	-	4,937	5,925	4,875	3,822	3,481

Source: S&P Global Market Intelligence. Standard template. Financial Sources.